» Articles » PMID: 25209391

Glucose Induces Intestinal Human UDP-glucuronosyltransferase (UGT) 1A1 to Prevent Neonatal Hyperbilirubinemia

Overview
Journal Sci Rep
Specialty Science
Date 2014 Sep 12
PMID 25209391
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Inadequate calorie intake or starvation has been suggested as a cause of neonatal jaundice, which can further cause permanent brain damage, kernicterus. This study experimentally investigated whether additional glucose treatments induce the bilirubin-metabolizing enzyme--UDP-glucuronosyltransferase (UGT) 1A1--to prevent the onset of neonatal hyperbilirubinemia. Neonatal humanized UGT1 (hUGT1) mice physiologically develop jaundice. In this study, UGT1A1 expression levels were determined in the liver and small intestine of neonatal hUGT1 mice that were orally treated with glucose. In the hUGT1 mice, glucose induced UGT1A1 in the small intestine, while it did not affect the expression of UGT1A1 in the liver. UGT1A1 was also induced in the human intestinal Caco-2 cells when the cells were cultured in the presence of glucose. Luciferase assays demonstrated that not only the proximal region (-1300/-7) of the UGT1A1 promoter, but also distal region (-6500/-4050) were responsible for the induction of UGT1A1 in the intestinal cells. Adequate calorie intake would lead to the sufficient expression of UGT1A1 in the small intestine to reduce serum bilirubin levels. Supplemental treatment of newborns with glucose solution can be a convenient and efficient method to treat neonatal jaundice while allowing continuous breastfeeding.

Citing Articles

Validating Disease Associations of Drug-Metabolizing Enzymes through Genome-Wide Association Study Data Analysis.

Leskiw E, Whaley A, Hopwood P, Houston T, Murib N, Al-Falih D Genes (Basel). 2024; 15(10).

PMID: 39457450 PMC: 11507559. DOI: 10.3390/genes15101326.


Establishment of UGT1A1-knockout human iPS-derived hepatic organoids for UGT1A1-specific kinetics and toxicity evaluation.

Shintani T, Imamura C, Ueyama-Toba Y, Inui J, Watanabe A, Mizuguchi H Mol Ther Methods Clin Dev. 2023; 30:429-442.

PMID: 37663646 PMC: 10471830. DOI: 10.1016/j.omtm.2023.08.003.


Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ.

Zhu Y, Guan X, Chen J, Peng S, Finel M, Zhao Y Front Pharmacol. 2021; 11:628314.

PMID: 33628187 PMC: 7897654. DOI: 10.3389/fphar.2020.628314.


Earlier Nutrient Fortification of Breastmilk Fed LBW Infants Improves Jaundice Related Outcomes.

Ma X, Fan W Nutrients. 2020; 12(7).

PMID: 32708857 PMC: 7400820. DOI: 10.3390/nu12072116.


Experimental models assessing bilirubin neurotoxicity.

Bortolussi G, Muro A Pediatr Res. 2019; 87(1):17-25.

PMID: 31493769 DOI: 10.1038/s41390-019-0570-x.


References
1.
Gourley G . Bilirubin metabolism and kernicterus. Adv Pediatr. 1997; 44:173-229. View

2.
Temme E, Zhang J, Schouten E, Kesteloot H . Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 2002; 12(10):887-94. DOI: 10.1023/a:1013794407325. View

3.
Landers J, Bunce N . The Ah receptor and the mechanism of dioxin toxicity. Biochem J. 1991; 276 ( Pt 2):273-87. PMC: 1151088. DOI: 10.1042/bj2760273. View

4.
Newman A, Gross S . HYPERBILIRUBINEMIA IN BREAST-FED INFANTS. Pediatrics. 1963; 32:995-1001. View

5.
Maglich J, Stoltz C, Goodwin B, Hawkins-Brown D, Moore J, Kliewer S . Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 2002; 62(3):638-46. DOI: 10.1124/mol.62.3.638. View